#adalimumab

Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in High-Risk Patients

Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in High-Risk Patients

In a groundbreaking approach to neurodegenerative disease research, a team of Yale-led scientists has launched a major clinical...

Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in At-Risk Patients

Yale-Led Clinical Trial Investigates Anti-Inflammatory Drug Adalimumab to Prevent Parkinson’s Disease in At-Risk Patients

In a groundbreaking endeavor that bridges neurology, sleep medicine, and immunology, researchers at the Yale School of Medicine...

Yale Researchers Launch Landmark Clinical Trial to Test Anti-Inflammatory Drug Adalimumab for Preventing Parkinson’s Disease

Yale Researchers Launch Landmark Clinical Trial to Test Anti-Inflammatory Drug Adalimumab for Preventing Parkinson’s Disease

In a groundbreaking endeavor that bridges neurology, immunology, and sleep medicine, a team of Yale-led researchers has officially...